Generated by AI
Establishment Labs Holdings Inc. is a medical technology company focused on breast aesthetics and reconstructive plastic surgery. Its core portfolio includes silicone gel-filled breast implants under the Motiva Implants brand, along with breast tissue expanders and related surgical technologies used in augmentation and reconstruction procedures. The company serves physicians, hospitals, and clinics through a combination of direct sales and distributor networks, supporting commercial activity across Europe, the Middle East, Africa, Latin America, Asia, and the United States. Establishment Labs Holdings Inc. also develops products and platforms designed to support surgical planning and procedural workflows in aesthetic and reconstructive care. Headquartered in Austin, Texas, the company plays a specialized role in the global medical device market by supplying devices centered on women’s health, breast reconstruction, and aesthetic surgery.
Website11401 century oaks terrace
Austin, TX, 78758
United States
The latest articles about ESTA.
Establishment Labs Holdings reported Q3 2026 sales of US$71.99 million and a net loss of US$10.71 million, with nine month sales at US$199.41 million and a loss of US$35.84 million, while also narrowing basic loss per share versus the prior year periods. The business coupled higher sales with a reduced loss profile and increased its 2026 revenue outlook to more than US$274 million. This signals management’s confidence in demand and operating execution. We will now look at how Establishment...
Summary of May 19's posts. Generated by AI.
Summary of Nov 5's posts. Generated by AI.
Motley Fool Press Release.
Summary of Sep 27's posts. Generated by AI.
Investors talking about ESTA also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.